Innovative Medicine

* * *In process of launching 6 key pharmaceuticals products since 2009* * *Executing therapeutic area strategy and advancing key compounds in pipeline* * *Leveraging global market strategies using local insights to successfully grow market share and expand geographic presence* * *

Sirukumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis in Patients with Active Disease Despite Treatment with Methotrexate

Results Presented from the STELARA™ Clinical Development Program Also Demonstrate Consistency of Response across Multiple Ethnic Populations

Automated process gives researchers a simple, reliable method to capture and count circulating melanoma cells

Third medication for Tibotec Therapeutics HIV treatment portfolio

Study Findings Show Efficacy of STELARA in Patients Who Previously Had Inadequate Response to Tumor Necrosis Factor Antagonists